Stardust Solar Energy Inc. Secures Positive Resolution with SinuSafe Medical Ltd.

In This Article:

Vancouver, British Columbia--(Newsfile Corp. - November 27, 2024) - Stardust Solar Energy Inc. (TSXV: SUN) ("Stardust Solar" or the "Company"), a leading provider of residential solar energy solutions, is pleased to announce that it has entered into a settlement agreement dated November 26, 2024 (the "Settlement Agreement") with SinuSafe Medical Ltd. ("SinuSafe").

Pursuant to the Settlement Agreement, as full and final settlement of the amounts owed to the Company by SinuSafe under the Loan Agreement (as defined herein), SinuSafe agreed to pay to the Company the sum of $395,208 (the "Settlement Amount") within 45 days of the date on which the judgment for the Settlement Agreement becomes effective, and in any case by no later than December 31, 2024.

Within three business days of the Company's receipt of the Settlement Amount, the Company will submit a request for the removal of all the Company's liens, restrictions or similar encumbrances imposed on SinuSafe's patents or intellectual property.

Background

In March 2022, the Company (formerly Bold Capital Enterprises Ltd.) entered into an arm's length letter of intent with SinuSafe, pursuant to which the Company and SinuSafe intended to complete a transaction whereby the Company would acquire all of the issued and outstanding shares in the share capital of SinuSafe (the "Transaction"). In connection with the proposed Transaction, in May 2022, the Company executed a secured loan agreement (the "Loan Agreement") with SinuSafe pursuant to which it loaned SinuSafe the principal amount of $350,000. The loan is secured against the core assets of SinuSafe, namely its patent and patent applications, has a term of 12 months and bears interest at a rate of 5% payable at maturity.

In November 2022, the Company announced that the parties agreed to an extension for the negotiation and signature of a definitive agreement from October 31, 2022 to January 31, 2023.

On March 31, 2023, the Company announced that it decided not to grant any further extensions for the consummation of the Transaction and, unfortunately, the proposed Transaction lapsed. As a consequence of the termination of the proposed Transaction, the Company demanded that SinuSafe repay the secured loan in the principal amount of $350,000, as well as accrued and unpaid interest, the whole as contemplated in the Loan Agreement.

The Company, through its Israeli legal counsel, appeared before the Israeli court at the pre-hearing held on September 17, 2024 and which was scheduled to consider certain matters pertaining to the Company's proceedings against SinuSafe in respect of the amounts payable to the Company under the Loan Agreement.